ArticleAntimicrobial agents and chemotherapy2020

Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration.

Peter Hnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.